PMC:7784786 / 629-836
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"28","span":{"begin":87,"end":91},"obj":"Gene"},{"id":"31","span":{"begin":118,"end":126},"obj":"Species"},{"id":"32","span":{"begin":145,"end":153},"obj":"Species"},{"id":"34","span":{"begin":6,"end":16},"obj":"Chemical"},{"id":"35","span":{"begin":57,"end":67},"obj":"Chemical"}],"attributes":[{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Gene:3569"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:9606"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:9606"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:C000597346"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" with itolizumab as part of an expanded access protocol. Itolizumab was able to reduce IL-6 concentrations in all the patients. Two of the three patients showed respiratory and radiological improvement and w"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":57,"end":127},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" with itolizumab as part of an expanded access protocol. Itolizumab was able to reduce IL-6 concentrations in all the patients. Two of the three patients showed respiratory and radiological improvement and w"}